Exhibit 99.1
						------------


Monday, April 16, 8:05 a.m. Eastern Time

Press Release

SOURCE:  Park Pharmacy Corporation

Park Pharmacy Announces Sale of Florida Infusion Pharmacy

DALLAS, April 16 /PRNewswire/ -- Park Pharmacy Corporation (OTC
Bulletin Board: PPRX - news) today announced that its Park
Infusion Services subsidiary has completed the sale of its St.
Petersburg, Fla., infusion pharmacy and ambulatory infusion
center to Option Care Enterprises, Inc. of Bannockburn, Ill.,
effective April 1.

The pharmacy is a full-service provider of infusion services,
including total parenteral nutrition, chemotherapy, antibiotic
therapy and other services. Option Care provides specialty
pharmaceutical products and related services, infusion therapy
and other ancillary healthcare services through a national
network of 130 company-owned and franchise offices in 32 states.

Under the terms of the transaction, Park Infusion received
approximately $900,000 in cash at closing. A contingent payment
of up to $380,000 will be due within 120 days based on the
accomplishment of certain objectives. Park Infusion retained all
cash and accounts receivable and sold the pharmacy's inventory,
payor contracts, patient list, furniture and fixtures, and
general intangibles. As of February 28, accounts receivable for
the St. Petersburg location were $1.1 million.

"The sale of our St. Petersburg infusion pharmacy was a win-win
for all involved," explained Tom Baker, Chief Executive Officer
of Park Pharmacy. "We made the determination that although the
St. Petersburg location was performing quite well, it did not fit
into our stated strategy of being a provider of high-end and
technical pharmacy products and services in major metropolitan
areas throughout Texas and the surrounding states. We're losing
some good people, and Option Care is buying this operation just
as it is hitting a strong stride. We wish them well."

Baker added, "This transaction is important to Park for several
reasons. First, it obviously solidifies our focus on Texas and
the Southwest. Our existing operations are now all in Texas, and
our acquisition efforts will focus there. Second, the sale is
proof positive that we can create value for our shareholders.
When we bought the St. Petersburg pharmacy, along with infusion
pharmacies in Dallas and San Antonio, we paid $1,750,000. In this
transaction alone, we stand to recoup potentially $1,280,000, and
at the time we bought them, St. Petersburg represented less than
10% of the cash flow between the three locations. Finally, the
sale boosts our liquidity and enhances our overall financial
flexibility."

About Park Pharmacy

Park Pharmacy Corporation, based in Dallas, Tex., is developing,
through acquisition, a regional network of successful community
and specialty pharmacies focusing on high-end and technical
pharmacy services. Services provided by its various divisions
include retail community

<PAGE>


drugstores offering a comprehensive inventory of medicines and a
unique breadth and depth of pharmacy services, including infusion
and compounding pharmacy, retail pharmacy providing both durable
and home medical equipment, home care/institutional pharmacies,
wholesale medical supply and technical pharmacy services.
Additionally, the Company's subsidiary, Rx-Pro, Inc., provides
electronic patient charting, medical records and prescription
transmission via the Internet and wireless Web, creating a
paperless work environment for pharmacists, physicians, nurses
and assisted living facility personnel.

Cautionary Statement Regarding Forward-Looking Statements

Statements in this release that are not purely historical facts,
including statements about anticipated or expected future revenue
and earnings growth and profitability, are forward-looking
statements within the meaning of Section 27A of the Securities
Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. All forward-looking statements
in this release are based only upon information available to Park
Pharmacy Corporation on the date of this release. All forward-
looking statements involve risks and uncertainties that could
cause actual events or results to differ materially from the
events or results described in the forward-looking statements,
including challenges in integrating acquired businesses, changing
consumer preferences, lack of success of new businesses, loss of
Park's customers, competition, and other factors discussed from
time to time in Park's filings with the Securities and Exchange
Commission, including, without limitation, factors discussed
under the caption "Certain Business Factors" in Park's annual
report on Form 10-K dated June 30, 2000.

     FOR MORE INFORMATION:
     John Sommerhalder
     Park Pharmacy
     214-692-9921, ext. 17

SOURCE: Park Pharmacy Corporation